v3.20.2
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities    
Net loss for the period $ (3,634,698) $ (5,503,328)
Adjustment for items not affecting cash    
Depreciation 34,231 51,029
Amortization 47,008 138,628
Interest expense 181,481 167,877
Share based compensation expense 620,254 925,976
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities (2,751,724) (4,219,818)
Changes in non-cash working capital items    
Accounts receivable 189,349 1,041,848
Prepaid expenses and other receivables (38,743) (837,145)
Due from related parties (1,311) (347)
Inventories 169,141 (631,376)
Accounts payable (327,475) 285,315
Accrued liabilities (31,031) (512,068)
Deferred revenue (89,813) 122,821
Net cash (used in) operating activities (2,881,607) (4,750,770)
Investing activities    
Acquisition of equipment 0 (91,141)
Net cash (used in) investing activities 0 (91,141)
Financing activities    
Proceeds from convertible loans 1,502,575 9,070,000
Proceeds from PPP Loan 459,912 0
Repayment of term loan 0 (500,000)
Proceeds from term loan 0 500,000
Net cash provided by financing activities 1,962,487 9,070,000
Net increase in cash and cash equivalents for the period (919,120) 4,228,089
Cash and cash equivalents, beginning of the period 2,269,747 446,779
Cash and cash equivalents, end of the period $ 1,350,627 $ 4,674,868

Source